Geoffrey Gill, CEO, Verisense Health

Geoff Gill has transitioned from his role as President of Shimmer Americas to lead the Verisense Health spin-off from Shimmer. Gill’s primary role at Shimmer was as a member of the global management team with particular focus on business and product strategy for the consumer neuroscience and medical markets. Prior to Shimmer, Gill performed a wide variety of roles at Innerscope Research, Inc., a leading consumer neuroscience company, most recently as CFO/SVP of Operations. Other experience includes VP of R&D for Bayer Diagnostics Critical Care division and Global Market Manager at Weidmann Electrical Technology. Gill has a AB in Applied Math and Physics from Harvard University and an MS in Management of Technology from the MIT Sloan School of Management.